Self-attenuating adenovirus enables production of recombinant adeno-associated virus for high manufacturing yield without contamination

Recombinant adeno-associated virus (rAAV) shows great promise for gene therapy, however scalability, yield and quality remain significant issues. Here we describe an rAAV manufacturing strategy using a ‘helper’ adenovirus that self-inhibits its major late promoter (MLP) to truncate its own replicati...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Weiheng, Patrício, Maria I., Duffy, Margaret R., Krakowiak, Jakub M., Seymour, Leonard W., Cawood, Ryan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901928/
https://www.ncbi.nlm.nih.gov/pubmed/35256603
http://dx.doi.org/10.1038/s41467-022-28738-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901928/
https://www.ncbi.nlm.nih.gov/pubmed/35256603
http://dx.doi.org/10.1038/s41467-022-28738-2

Ejemplares similares